The remaining 55 RNA‐negative samples had BCR‐ABL1 levels around MR4.0, indicating the benefit of supplementary DNA quantification for detection of quiescent, transcript‐negative, CML cells. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.